Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

80 Mile shares soar on new Greenland asset valuation

(Sharecast News) - The share price of AIM-listed metals group 80 Mile more than doubled on Wednesday after its 30% stake in the Jameson liquid hydrocarbon project in Greenland was valued at $92m. The news follows the merger between Nasdaq-listed Pelican Acquisition Corporation and March GL subsidiary Greenland Exploration Limited, which has an agreement to earn up to 70% in the Jameson project.

The merger values March GL - which is funding 100% of the costs associated with drilling two exploration wells at Jameson - at around $215m valuation, implying a value of $92m for 80 Mile's stake.

"This deal has come after many months of hard work by many people across multiple organisations, whether they be financiers, international legal experts, oil industry experts, or the leaders of the individual companies themselves," said Roderick McIllree, executive director of 80 Mile subsidiary White Flame Energy, which holds the 30% interest.

"What we have now is one big machine that is aligned in its desire to prove the existence of one of the world's last remaining great untapped oil occurrences."

80 Mile's shares were up 142% at 0.78p by 1553 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.